Cytokine Regulation and Anti-Inflammatory Action of Amine-Carboxyborane
Author Information
Author(s): Margaret E. Murphy, Robert P. Shrewsbury, Anup Sood, Bernard F. Spielvogel, Amy L. Elkins, Iris Hall
Primary Institution: University of North Carolina Chapel Hill
Hypothesis
The amine-carboxyboranes will block cytokine release and reduce inflammation in L929 fibroblasts and IC-21 macrophages.
Conclusion
Amine-carboxyboranes effectively inhibit the release of TNF and IL-1, demonstrating their potential as anti-inflammatory agents.
Supporting Evidence
- Amine-carboxyboranes reduced TNF release from IC-21 macrophages significantly.
- IL-1 release from P388D cells was inhibited by 100% at certain concentrations of the compounds.
- The compounds showed a concentration-response effect on cytokine release.
- Calcium uptake in L929 cells was significantly decreased by the compounds.
- Proline incorporation into collagen was enhanced in the presence of the compounds.
Takeaway
This study shows that certain compounds can help reduce inflammation by blocking substances that cause it in cells.
Methodology
The study involved synthesizing amine-carboxyborane derivatives and testing their effects on cytokine release and receptor binding in mouse macrophages and fibroblasts.
Limitations
The study primarily focuses on in vitro results, which may not fully translate to in vivo conditions.
Participant Demographics
The study used IC-21 mouse macrophages and L929 mouse fibroblasts.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website